Logo-npj
Submitted: 04 Nov 2021
Accepted: 07 Dec 2021
ePublished: 18 Dec 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Nephropharmacol. 2022;11(2): e10453.
doi: 10.34172/npj.2022.10453
  Abstract View: 2373
  PDF Download: 176

Case Report

Acquired hemophilia in a patient with SARS-CoV-2 infection; a case report

Ali Hajigholami 1* ORCID logo, Hourieh Ansari 2 ORCID logo, Sakineh Ansari 1 ORCID logo, Shakiba Hassanzadeh 3 ORCID logo

1 Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Community and Preventive Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3 Nickan Research Institute, Isfahan, Iran
*Corresponding Author: Corresponding author: Ali Hajigholami, Email: , Email: alihajigholami@med.mui.ac.ir

Abstract

Acquired hemophilia (AH) is a potentially life-threatening hemorrhagic disorder. We report the second confirmed case of COVID-19-associated AH in a 45-year-old female which, unfortunately, expired as her treatment failed. She presented to the emergency department with abnormal bleeding and spontaneous hemoptysis about ten days after a removal surgery of her epiglottis tumor. Aggregation tests, such as partial thromboplastin time (PTT), are recommended in patients with COVID-19 infection that have bleeding episodes.

Implication for health policy/practice/research/medical education:

Acquired hemophilia is a potentially life-threatening hemorrhagic disorder. There have been various reports of COVID-19- associated acquired hemophilia. Aggregation tests, such as partial thromboplastin time (PTT), are recommended in patients with COVID-19 infection that have bleeding episodes.

Please cite this paper as: Hajigholami A, Ansari H, Ansari S, Hassanzadeh S. Acquired hemophilia in a patient with SARSCoV-2 infection; a case report. J Nephropharmacol. 2022;11(2):e10453. DOI: 10.34172/npj.2022.10453.

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 2374

Your browser does not support the canvas element.


PDF Download: 176

Your browser does not support the canvas element.